Global Leukaphereis Product Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Leukaphereis Product Market Insights, Forecast to 2034
Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications are some of the factors driving the growth of these markets.
Market Analysis and InsightsGlobal Leukaphereis Product Market
Global Leukaphereis Product market is expected to reach to US$ 936 million in 2023, with a positive growth of %, compared with US$ 825 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Leukaphereis Product industry is evaluated to reach US$ 1485.3 million in 2033. The CAGR will be 8.0% during 2023 to 2033.
Globally, Leukaphereis Product key companies include Asahi Kasei Medical, Fresenius, Haemonetics, Terumo BCT, Macopharma, Miltenyi Biotec, Guangzhou Daji Medical Science and Technology, MEDICA and PuriBlood Medical, etc. Asahi Kasei Medical, Fresenius, Haemonetics are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Leukaphereis Product were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Leukaphereis Product market and estimated to attract more attentions from industry insiders and investors.
Leukaphereis Product can be divided into Leukapheresis Disposables and Leukapheresis Devices, etc. Leukapheresis Disposables is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Leukaphereis Product is widely used in various fields, such as Research Applications and Therapeutic Applications, etc. Research Applications provides greatest supports to the Leukaphereis Product industry development. In 2022, global % revenue of Leukaphereis Product went into Research Applications filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Leukaphereis Product market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Leukaphereis Product market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Asahi Kasei Medical
Fresenius
Haemonetics
Terumo BCT
Macopharma
Miltenyi Biotec
Guangzhou Daji Medical Science and Technology
MEDICA
PuriBlood Medical
Charles River Laboratories
AllCells
StemExpress
Segment by Type
Leukapheresis Disposables
Leukapheresis Devices
Research Applications
Therapeutic Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Leukaphereis Product introduction, etc. Leukaphereis Product Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Leukaphereis Product
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Leukaphereis Product Market
Global Leukaphereis Product market is expected to reach to US$ 936 million in 2023, with a positive growth of %, compared with US$ 825 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Leukaphereis Product industry is evaluated to reach US$ 1485.3 million in 2033. The CAGR will be 8.0% during 2023 to 2033.
Globally, Leukaphereis Product key companies include Asahi Kasei Medical, Fresenius, Haemonetics, Terumo BCT, Macopharma, Miltenyi Biotec, Guangzhou Daji Medical Science and Technology, MEDICA and PuriBlood Medical, etc. Asahi Kasei Medical, Fresenius, Haemonetics are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Leukaphereis Product were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Leukaphereis Product market and estimated to attract more attentions from industry insiders and investors.
Leukaphereis Product can be divided into Leukapheresis Disposables and Leukapheresis Devices, etc. Leukapheresis Disposables is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Leukaphereis Product is widely used in various fields, such as Research Applications and Therapeutic Applications, etc. Research Applications provides greatest supports to the Leukaphereis Product industry development. In 2022, global % revenue of Leukaphereis Product went into Research Applications filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Leukaphereis Product market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Leukaphereis Product market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Asahi Kasei Medical
Fresenius
Haemonetics
Terumo BCT
Macopharma
Miltenyi Biotec
Guangzhou Daji Medical Science and Technology
MEDICA
PuriBlood Medical
Charles River Laboratories
AllCells
StemExpress
Segment by Type
Leukapheresis Disposables
Leukapheresis Devices
Segment by Application
Research Applications
Therapeutic Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Leukaphereis Product introduction, etc. Leukaphereis Product Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Leukaphereis Product
Chapter 13Methodology and Data Sources adopted by MRAResearch